Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Cronos Group Inc.

Get SEC filing alerts via email and in your feed for Cronos Group Inc.

CRON

Cronos Group Inc.

About Cronos Group Inc.

Cronos Group is a global cannabinoid company focused on research, product development, and building iconic brands in the cannabis industry. It operates in medical and adult-use markets across Canada, Israel, Germany, the UK, and Australia. The company develops and distributes cannabis products, manages cultivation and manufacturing facilities, and invests in strategic partnerships and intellectual property to create value and differentiate its offerings.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Cronos Group Inc.

1
1
Cronos Group Inc. Cronos Group Inc. Reports 40% Revenue Growth to $45.2 Million in Q1 2026

Via official filing (AI summary) | 25 days ago | 0 comments

2
1
Cronos Group Inc. Cronos Group Inc. Reports 25% Revenue Growth to $146.6 Million for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Cronos Group Inc. Cronos Group Reports 6% Revenue Growth to $36.3 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Cronos Group Inc. Cronos Group Reports 21% Revenue Growth to $33.5 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Cronos Group Inc. Cronos Group Inc. Reports 28% Revenue Growth to $32.3 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Cronos Group Inc. Cronos Group Reports 38% Revenue Growth, Improved Net Income in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments